Contract awardedAseptic compounding, specials and contract pharmaceutical manufacturing

Lentiviral vector for a University of Edinburgh gene therapy trial

The University of Edinburgh bought a high titre lentiviral vector, made to GMP standard, from Indiana University for a phase I/II gene therapy trial. The therapy modifies a patient's own CD34+ stem cells to treat a rare genetic disease that brings on dementia in children.

Indiana University must produce a 30 litre unconcentrated harvest from 293T cells and concentrate it by about 100 to 200 times. Quality control follows FDA rules, and the first delivery goes straight to the University of California, Los Angeles.

The university estimated the work at £900,000. One bid came in, and the award was £586,904. The contract runs for a year, with options to buy more deliveries over a further two.

What
Aseptic compounding, specials and contract pharmaceutical manufacturing
1 of 2 lots awarded
Value
£586,904
Across 1 lots
How it was bought
Competitive procedure with negotiation
1 bid
Dates and next
7 Nov 2025

Lots and suppliers

1 of 2 lots awarded
LotWhatSupplierValue
Lot 1Lot 1Indiana University£586,904
Lot 1Lot 1Not awarded·

How it was bought

4 official notices
  1. 30 Jul 2025Tender noticeFind a Tender
  2. 1 Sep 2025Bids closed1 bid
  3. 8 Dec 2025Award noticePublic Contracts Scotland
  4. 8 Dec 2025Award noticeFind a Tender
  5. 8 Dec 2025Award noticePublic Contracts Scotland

University of Edinburgh has bought this 8 times since 2021

Last bought
Apr 2026
Typical length
2 years
Typical value
£115,988
Suppliers used
5
AwardedContractWon byValue
Apr 2026LockedLocked£192,482
Nov 2025This purchase3 yearsIndiana University£586,904
Aug 2025Locked1 yearLocked£75,135
Mar 2025LockedLocked£183,944
Sep 2022LockedLocked£51,316

and 3 more

Suppliers University of Edinburgh has used

SupplierContractsValue
Indiana University Won this one2£662,039
Locked2£299,932
Locked2£84,995
Locked1£192,482
Locked1£51,316
See the contracts and who won them

Figures to 21 November 2026

How it compares

With every aseptic compounding, specials and contract pharmaceutical manufacturing award since 2021

Half of awards fall between £89,225 and £1.21mMedian £250,114

Awards
79
Firms that won them
64
Median award
£250,114
of 69 with a value
This award
Bigger than 64%
of them
Typical length
2 years
In Scotland
14 awards

Indiana University ranks 8th of 64 firms for aseptic compounding, specials and contract pharmaceutical manufacturing awards since 2021.

RankFirmAwardsValue
1Locked7£36.6m
2Locked5£16.1m
3Locked4£16.8m
4Locked3£30.6m
4Locked3£1.75m
4Locked3£197,829
8Indiana University Won this one2·
See who wins this work

Aseptic compounding, specials and contract pharmaceutical manufacturing at other buyers

University of Edinburgh has awarded 865 contracts since 2021.

See University of Edinburgh's page
  • Indiana University has won 3 public contracts since 2021, 2 of them from University of Edinburgh.

    • Nov 2025This purchase
    • Aug 2025Locked
    See the contracts

1 aseptic compounding, specials and contract pharmaceutical manufacturing tender is open now

See it
More aseptic compounding, specials and contract pharmaceutical manufacturing contracts awarded in 2025